Alpha Tau Medical Ltd. (DRTSW)
0.30
-0.05 (-14.29%)
At close: Jan 15, 2025, 10:44 AM
Company Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.
Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.
The company was founded in 2015 and is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd.
| Country | IL |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 121 |
| CEO | Uzi Sofer |
Contact Details
Address: Building B3 Jerusalem, IL | |
| Website | https://www.alphatau.com |
Stock Details
| Ticker Symbol | DRTSW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001871321 |
| CUSIP Number | M0740A116 |
| ISIN Number | IL0011839466 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Uzi Sofer | Chief Executive Officer & Chairman |
| Raphi Levy | Chief Financial Officer |
| Ronen Segal | Chief Technology Officer |
| Amnon Gat | Chief Operations Officer |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Peter M. Melnyk | Chief Commercial Officer |
| Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board |
| Rebecca Becker | Vice President of legal |
| Yael Zeiger | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 18, 2024 | 6-K | Filing |
| Dec 17, 2024 | 6-K | Filing |
| Dec 17, 2024 | 6-K | Filing |
| Dec 11, 2024 | 6-K | Filing |
| Dec 06, 2024 | 6-K | Filing |
| Nov 19, 2024 | 6-K | Filing |
| Nov 13, 2024 | 6-K | Filing |
| Nov 12, 2024 | 6-K | Filing |
| Oct 21, 2024 | 6-K | Filing |
| Oct 10, 2024 | 6-K | Filing |